Uncertainty in the business environment due to the resurgence of COVID-19 infections
First written in FY2023-Q2. 4 of 8 entries say "Restated". Latest entry: FY2025.
1 other company's latest entry also says "Dropped".
- FY2025DroppedAnnual reportThis filing does not describe the risk of renewed infection spread by specifically naming COVID-19, and the discussion has shifted to general infectious-disease risks.
- FY2024RestatedAnnual report
「Although COVID-19 is not currently spreading within the Group, an outbreak at a facility could reduce confidence in the Group and lower facility occupancy rates.」
While stating that there is no spread of infection within the company, it continues to describe an outbreak at a facility as a future risk. - FY2024-Q3RestatedAnnual report
「Following the reclassification of COVID-19 as a Category V infectious disease, normalization of economic and social activity progressed, but」
It continues to describe the normalization of economic and social activity following the Category V reclassification as a business-environment factor. - FY2024-Q2RestatedAnnual report
「Following the reclassification of COVID-19 as a Category V infectious disease, normalization of economic and social activity progressed, but」
It reconfirms the normalization of economic and social activity following the Category V reclassification and continues to describe a reduced level of risk compared with the period of renewed infection spread. - FY2024-Q1MitigatedAnnual report
「As COVID-19 was reclassified as a Category V infectious disease and infections were relatively well contained, normalization of economic and social activity progressed」
It states that the legal classification of COVID-19 was changed to Category V and that infections were relatively well contained, indicating reduced risk compared with the previous period of renewed infection spread. - FY2023SoftenedAnnual report
「Although COVID-19 is not currently spreading within the Group, an outbreak at a facility could reduce confidence in the Group and lower facility occupancy rates.」
While stating that there is no spread of infection within the company, it describes the impact of an outbreak as a future risk, indicating a less severe risk profile than in the previous description of renewed infection spread. - FY2023-Q3RestatedAnnual report
「During the seventh wave, infections with the new Omicron subvariant BA.5 spread and the number of cases reached a record high, but no restrictions on activities were imposed in order to maintain social activity」
The spread of infections caused by BA.5 and the seventh wave continue to be described as business-environment factors. - FY2023-Q2First statedAnnual report
「As infections with the new Omicron subvariant BA.5 spread again and the infection situation deteriorated significantly during the seventh wave, economic activity during the period had to continue under thorough infection-control measures.」
The resurgence of infections and deterioration during the seventh wave are described as actual business-environment factors.